Cardiff Oncology ( NASDAQ:CRDF – Get Rating ) released its earnings results on Thursday. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.05, reports. Cardiff Oncology had a negative net margin of 10,033.16% and a negative return on equity of 31.94%. The firm had revenue of $0.13 million for the quarter, compared to analyst estimates of $0.08 million. Cardiff Oncology Stock Performance Shares of CRDF opened at $1.76 on Friday. The firm has a 50 day simple moving average of $1.

https://www.dailypolitical.com/2023/03/05/cardiff-oncology-nasdaqcrdf-announces-earnings-results.html

#dailypolitical